Showing results (161-170 of 216) with videos related to
Sort By:
Pageof 22
Cancer Immunology, Immunotherapy : CII|December 31, 2004
Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen TnElla Kagan, Govind Ragupathi, San San Yi, et al.Journal of the American Chemical Society|August 1, 2002
The structural basis for induction of VanB resistanceSteven D Dong, Markus Oberthür, Heather C Losey, et al.Journal of Bacteriology|January 8, 2013
The Escherichia coli Lpt transenvelope protein complex for lipopolysaccharide export is assembled via conserved structurally homologous domainsRiccardo Villa, Alessandra M Martorana, Suguru Okuda, et al.Environmental Toxicology and Chemistry|July 11, 2008
DNA microarrays detect effects of soil contamination on Arabidopsis thaliana gene expressionKimberly D Magrini, Amit Basu, James R Spotila, et al.Journal of the American Geriatrics Society|December 12, 2007
Kidney transplantation in elderly people: the influence of recipient comorbidity and living kidney donorsChristine Wu, Ron Shapiro, Henkie Tan, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2009
The significance of renal C4d staining in patients with BK viruria, viremia, and nephropathyIbrahim Batal, Hanady Zainah, Sean Stockhausen, et al.Chemistry & Biology|December 25, 2002
Incorporation of glucose analogs by GtfE and GtfD from the vancomycin biosynthetic pathway to generate variant glycopeptidesHeather C Losey, Jiqing Jiang, John B Biggins, et al.Human Pathology|April 24, 2009
Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunctionIbrahim Batal, Zachary M Franco, Ron Shapiro, et al.Transplantation|June 26, 2007
Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapyDemetrius Ellis, Ron Shapiro, Michael Moritz, et al.Annals of Transplantation|October 1, 2011
Outcomes of renal transplantation in recipients with peak panel reactive antibody >30% under tacrolimus-based immunosuppressionAmit Basu, John Falcone, Igor Dvorchik, et al.Pageof 22